Intracellular Th Stock Alpha and Beta Analysis
| ITCI Stock | USD 131.26 0.10 0.08% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Intracellular Th. It also helps investors analyze the systematic and unsystematic risks associated with investing in Intracellular over a specified time horizon. Remember, high Intracellular's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Intracellular's market risk premium analysis include:
Beta (0.03) | Alpha 0.75 | Risk 4.8 | Sharpe Ratio 0.17 | Expected Return 0.81 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Intracellular |
Intracellular Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Intracellular market risk premium is the additional return an investor will receive from holding Intracellular long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Intracellular. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Intracellular's performance over market.| α | 0.75 | β | -0.03 |
Intracellular expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Intracellular's Buy-and-hold return. Our buy-and-hold chart shows how Intracellular performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Intracellular Market Price Analysis
Market price analysis indicators help investors to evaluate how Intracellular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intracellular shares will generate the highest return on investment. By understating and applying Intracellular stock market price indicators, traders can identify Intracellular position entry and exit signals to maximize returns.
Intracellular Return and Market Media
The median price of Intracellular for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 127.02 with a coefficient of variation of 18.91. The daily time series for the period is distributed with a sample standard deviation of 21.26, arithmetic mean of 112.4, and mean deviation of 20.2. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 4730 shares by Durgam Suresh K. of Intracellular at 127.0 subject to Rule 16b-3 | 01/31/2025 |
2 | Acquisition by Mark Neumann of 11017 shares of Intracellular subject to Rule 16b-3 | 02/04/2025 |
3 | How Are Corporate Transactions Influencing Intra-Cellular Therapies | 02/18/2025 |
4 | Intra-Cellular Therapies Stock Rating Lowered by Mizuho | 02/24/2025 |
5 | ITCI Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders | 02/25/2025 |
6 | 2,622 Shares in Intra-Cellular Therapies, Inc. Acquired by Wealthspire Advisors LLC | 02/28/2025 |
7 | Acquisition by Mark Neumann of 18714 shares of Intracellular at 36.89 subject to Rule 16b-3 | 03/03/2025 |
8 | Disposition of 13133 shares by Halstead Michael of Intracellular subject to Rule 16b-3 | 03/06/2025 |
9 | Johnson Johnson Stops Late-Stage Depression Study Over Insufficient Efficacy | 03/07/2025 |
10 | Disposition of 7345 shares by Halstead Michael of Intracellular subject to Rule 16b-3 | 03/10/2025 |
11 | Intra-Cellular Therapies Hits New 1-Year High Whats Next | 03/11/2025 |
About Intracellular Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Intracellular or other stocks. Alpha measures the amount that position in Intracellular Th has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 110.16 | 89.62 | 89.26 | 71.42 | PTB Ratio | 7.59 | 11.61 | 7.5 | 7.71 |
Intracellular Upcoming Company Events
As portrayed in its financial statements, the presentation of Intracellular's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Intracellular's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Intracellular's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Intracellular. Please utilize our Beneish M Score to check the likelihood of Intracellular's management manipulating its earnings.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Intracellular
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Intracellular Backtesting, Intracellular Valuation, Intracellular Correlation, Intracellular Hype Analysis, Intracellular Volatility, Intracellular History and analyze Intracellular Performance. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Intracellular technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.